Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziprasidone in psychosis prodrome
NCT00635700Phase 2Completed
- Sponsor
- Yale University
- Start
- Mar 2008
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of ziprasidone in psychosis, sponsored by Yale University. Started Mar 2008; status: completed.
02
Drugs
ziprasidone
03
Conditions
psychosis
Beyond the preview
Go deeper on NCT00635700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00635700.